Loading the company…
Loading the company…
Families: Tumor ablation, Bronchoscopy & lung nodule.
All companies · Product and company coverage
In the last ten years FDA made 3 decisions for Serpex Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2026 (2). The latest was on 2026-09-02.
| Family | Decisions on record |
|---|---|
| Tumor ablation | 2 |
| Bronchoscopy & lung nodule | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-09-02 | 510(k) | K262420 | Maverix Cryo Biopsy Pro (MCB Pro) (MCBP-1000); Maverix Cryo Cartridge (CC-1000) |
| 2026-06-30 | 510(k) | K261068 | Maverix Cryo Biopsy Probe (MCB1000);Maverix Cryo Cartridge (CC1000) |
| 2022-08-15 | 510(k) | K221302 | Recon Steerable Sheath |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Serpex Medical.